Pathstone Holdings’s AbCellera Biologics ABCL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $43.9K | Sell |
12,811
-8,052
| -39% | -$27.6K | ﹤0.01% | 2137 |
|
2025
Q1 | $46.5K | Sell |
20,863
-500
| -2% | -$1.12K | ﹤0.01% | 2168 |
|
2024
Q4 | $62.6K | Sell |
21,363
-10,140
| -32% | -$29.7K | ﹤0.01% | 2255 |
|
2024
Q3 | $81.9K | Buy |
31,503
+14,693
| +87% | +$38.2K | ﹤0.01% | 2247 |
|
2024
Q2 | $49.8K | Sell |
16,810
-228
| -1% | -$675 | ﹤0.01% | 2256 |
|
2024
Q1 | $77.2K | Buy |
17,038
+324
| +2% | +$1.47K | ﹤0.01% | 2224 |
|
2023
Q4 | $95.4K | Buy |
+16,714
| New | +$95.4K | ﹤0.01% | 2148 |
|